Literature DB >> 12569568

Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo.

Takeshi Kashima1, Kazuya Nakamura, Jitsutaro Kawaguchi, Masakatsu Takanashi, Tsuyoshi Ishida, Hiroyuki Aburatani, Akira Kudo, Masashi Fukayama, Agamemnon E Grigoriadis.   

Abstract

Osteosarcoma by nature shows aggressive pulmonary metastasis; however, the underlying molecular mechanisms remain unclear. We previously showed that N-cadherin and cadherin-11 (OB-cadherin), which are highly expressed in normal osteoblasts, are anomalously expressed in human osteosarcoma (Kashima et al., Am J Pathol 1999;155:1549-55). In the present study, we examined the role of cadherins in osteosarcoma metastasis using the mouse osteosarcoma cell line Dunn and its highly metastatic subline LM8. Oligonucleotide array and RT-PCR analyses demonstrated that Dunn and LM8 cells did not express appreciable levels of several members of the cadherin family, and Western blot analysis confirmed that Dunn and LM8 cells did not express P-cadherin, E-cadherin, N-cadherin or cadherin-11 protein. We therefore investigated the functional consequences of cadherin overexpression on cell migration and in vivo metastatic potential of LM8 cells. Several LM8 clones were isolated which expressed exogenous N-cadherin and cadherin-11 localized to the cell membrane and able to bind to beta-catenin. Overexpression of N-cadherin or cadherin-11 in LM8 cells did not affect cell proliferation but caused an inhibitory effect on cell migration in vitro. In vivo analysis showed that N-cadherin- and cadherin-11-overexpressing cells exhibited a marked reduction in their ability to form pulmonary metastases, with significant decreases in lung weight and the number and weight of metastatic lesions, as well as the size and weight of primary lesions at the s.c.-inoculated site. These observations demonstrate that disruption of N-cadherin- and cadherin-11-mediated cell-cell adhesion is critical in the pulmonary metastasis of osteosarcoma. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12569568     DOI: 10.1002/ijc.10931

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  44 in total

Review 1.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

2.  Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8.

Authors:  Yoshihiro Yui; Kazuyuki Itoh; Kiyoko Yoshioka; Norifumi Naka; Motonobu Watanabe; Yoshimi Hiraumi; Hiroshi Matsubara; Ken-ichiro Watanabe; Kazumi Sano; Tatsutoshi Nakahata; Souichi Adachi
Journal:  Clin Exp Metastasis       Date:  2010-09-26       Impact factor: 5.150

3.  Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution.

Authors:  Laila Illán Rubio; Bertrand Tavitian; Elina Zueva
Journal:  Clin Exp Metastasis       Date:  2009-11-11       Impact factor: 5.150

4.  A transcription co-factor integrates cell adhesion and motility with the p53 response.

Authors:  Amanda S Coutts; Louise Weston; Nicholas B La Thangue
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

5.  Enhanced cell-cell contact stability and decreased N-cadherin-mediated migration upon fibroblast growth factor receptor-N-cadherin cross talk.

Authors:  Thao Nguyen; Laurence Duchesne; Gautham Hari Narayana Sankara Narayana; Nicole Boggetto; David D Fernig; Chandrashekhar Uttamrao Murade; Benoit Ladoux; René-Marc Mège
Journal:  Oncogene       Date:  2019-07-16       Impact factor: 9.867

Review 6.  Beyond E-cadherin: roles of other cadherin superfamily members in cancer.

Authors:  Frans van Roy
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

Review 7.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

8.  Prognostic value of Twist and E-cadherin in patients with osteosarcoma.

Authors:  Ke Yin; Qiande Liao; Hongbo He; Da Zhong
Journal:  Med Oncol       Date:  2012-07-31       Impact factor: 3.064

9.  Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.

Authors:  Cressida A Lyon; Evgenia Koutsouki; Concepcion M Aguilera; Orest W Blaschuk; Sarah Jane George
Journal:  J Vasc Surg       Date:  2010-07-13       Impact factor: 4.268

10.  Identification and validation of genes with expression patterns inverse to multiple metastasis suppressor genes in breast cancer cell lines.

Authors:  Natascia Marino; Joshua W Collins; Changyu Shen; Natasha J Caplen; Anand S Merchant; Yesim Gökmen-Polar; Chirayu P Goswami; Takashi Hoshino; Yongzhen Qian; George W Sledge; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2014-08-03       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.